These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29718985)

  • 1. Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
    PLoS One; 2018; 13(5):e0197016. PubMed ID: 29718985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
    PLoS One; 2017; 12(9):e0184922. PubMed ID: 28945807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2020; 15(5):e0233739. PubMed ID: 32437439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.
    Zhou J; Hu SE; Tan SH; Cao R; Chen Y; Xia D; Zhu X; Yang XF; Ong CN; Shen HM
    Autophagy; 2012 Mar; 8(3):338-49. PubMed ID: 22302005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLOS Staff
    PLoS One; 2018; 13(1):e0191454. PubMed ID: 29329348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy blockade and lysosomal membrane permeabilization contribute to lead-induced nephrotoxicity in primary rat proximal tubular cells.
    Song XB; Liu G; Liu F; Yan ZG; Wang ZY; Liu ZP; Wang L
    Cell Death Dis; 2017 Jun; 8(6):e2863. PubMed ID: 28594408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C
    Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by ROS-Dependent ERK and JNK Activation.
    Wong CH; Iskandar KB; Yadav SK; Hirpara JL; Loh T; Pervaiz S
    PLoS One; 2016; 11(7):e0159352. PubMed ID: 27392019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Cd-induced autophagy and lysosomal activation in WRL-68 cells.
    Meng SF; Mao WP; Wang F; Liu XQ; Shao LL
    J Appl Toxicol; 2015 Nov; 35(11):1398-405. PubMed ID: 25639782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    Sardaro A; Saito K; Nakayama E; Valmori D
    PLoS One; 2016; 11(7):e0160538. PubMed ID: 27467222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression.
    PLOS ONE Staff
    PLoS One; 2019; 14(10):e0224843. PubMed ID: 31665187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sub-lethal oxidative stress induces lysosome biogenesis via a lysosomal membrane permeabilization-cathepsin-caspase 3-transcription factor EB-dependent pathway.
    Leow SM; Chua SX; Venkatachalam G; Shen L; Luo L; Clement MV
    Oncotarget; 2017 Mar; 8(10):16170-16189. PubMed ID: 28002813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2017; 12(1):e0170833. PubMed ID: 28107536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(8):e0183201. PubMed ID: 28793330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer.
    Kuzumaki N; Suzuki A; Narita M; Hosoya T; Nagasawa A; Imai S; Yamamizu K; Morita H; Suzuki T; Okada Y; Okano HJ; Yamashita JK; Okano H; Narita M
    PLoS One; 2013; 8(8):. PubMed ID: 29220846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function.
    Ma L; Xu Y; Su J; Yu H; Kang J; Li H; Li X; Xie Q; Yu C; Sun L; Li Y
    Int J Oncol; 2015 Nov; 47(5):1890-900. PubMed ID: 26397057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain 1 induce lysosomal permeabilization by cleavage of lysosomal associated membrane protein 2.
    Villalpando Rodriguez GE; Torriglia A
    Biochim Biophys Acta; 2013 Oct; 1833(10):2244-53. PubMed ID: 23747342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
    Liu K; Zheng D; Xu G; Du Z; Wu S
    PLoS One; 2018; 13(4):e0196618. PubMed ID: 29689114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells.
    Yu L; Wu WK; Gu C; Zhong D; Zhao X; Kong Y; Lin Q; Chan MT; Zhou Z; Liu S
    Oncotarget; 2016 Mar; 7(12):14693-707. PubMed ID: 26910910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.